|4Feb 1, 6:10 PM ET

Andersen Jill 4

4 · Adagio Therapeutics, Inc. · Filed Feb 1, 2022

Insider Transaction Report

Form 4
Period: 2022-01-30
Andersen Jill
Chief Legal Officer, Secretary
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-30+575,000575,000 total
    Exercise: $6.78Exp: 2032-01-29Common Stock (575,000 underlying)
Footnotes (1)
  • [F1]This option vests in equal monthly installments over a four-year period measured from one month following January 30, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION